The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Greenberg Robert J. since 2015.
The trader's CIK number is 1625594.
At the time of the last reporting, Greenberg Robert J. was the Chief Executive Officer of Pulse Biosciences, Inc.. (stock ticker symbol PLSE).
Also see all insider trading activities at Pulse Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | EYES | 0 | $0 | 18,744 | $82,289 | 8,223 | $41,115 |
| 2015 | EYES | 0 | $0 | 267,969 | $3,528,879 | 227,032 | $1,078,400 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | PLSE | 0 | $0 | 25,000 | $536,225 | 25,000 | $66,750 |
1. Second Sight Medical Products Inc (EYES)
2. Pulse Biosciences, Inc. (PLSE)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-12-01 | EYES | Sale | 1,950 | 1.96 | 3,822 |
| 2016-06-02 | EYES | Sale | 8,571 | 4.10 | 35,141 |
| 2016-04-18 | EYES | Option Ex | 8,223 | 5.00 | 41,115 |
| 2016-04-18 | EYES | Sale | 8,223 | 5.27 | 43,326 |
| 2015-12-07 | EYES | Option Ex | 17,969 | 4.75 | 85,352 |
| 2015-12-07 | EYES | Sale | 17,969 | 5.30 | 95,235 |
| 2015-06-03 | EYES | Option Ex | 71,847 | 4.75 | 341,273 |
| 2015-06-02 | EYES | Sale | 78,153 | 13.96 | 1,091,015 |
| 2015-06-03 | EYES | Sale | 71,847 | 14.12 | 1,014,479 |
| 2015-06-02 | EYES | Option Ex | 78,153 | 4.75 | 371,226 |
| 2015-03-23 | EYES | Sale | 1,258 | 13.40 | 16,857 |
| 2015-03-20 | EYES | Sale | 98,742 | 13.28 | 1,311,293 |
| 2015-01-01 | EYES | Option Ex | 59,063 | 4.75 | 280,549 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-05-10 | PLSE | Option Ex | 25,000 | 2.67 | 66,750 |
| 2017-05-10 | PLSE | Sale | 25,000 | 21.45 | 536,225 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Greenberg Robert J. (Chief Executive Officer of Pulse Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.